61
Participants
Start Date
August 22, 2019
Primary Completion Date
May 23, 2022
Study Completion Date
May 31, 2022
Clopidogrel
Both CKD and Non-CKD patients will be administered a 600-mg LD of clopidogrel followed by a single 75-mg MD administered after 24 hours.
Clopidogrel active metabolite
In both CKD and Non-CKD patients, blood samples collected at baseline only (before clopidogrel LD administration) will be incubated with escalating concentrations of clopidogrel active metabolite (1, 3 and 10 μM)
University of Florida Jacksonville, Jacksonville
Scott R. MacKenzie Foundation
OTHER
University of Florida
OTHER